Impairment of REM Sleep Architecture: A Potential Biomarker for Parkinson’s Progression
Objective: Our study finds that the effects of Parkinson’s disease on impairing normal REM sleep far surpass those of the RBD subpopulation alone. In fact,…Implementation of the Parkinson’s Disease-Health Index (PD-HI), a Novel, Validated, Disease-Specific Patient-Reported Outcome Measure, in a 24-Month Natural History Study
Objective: To evaluate and optimize the relevance, usability and longitudinal responsiveness of the Parkinson’s Disease-Health Index (PD-HI) for use in PD clinical trials. Background: The…Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease
Objective: To assess the feasibility of combining Mediterranean and ketogenic dietary principles in persons with Parkinson’s disease (PwP). Background: Dietary interventions have been proposed as…Self-perception of Health and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: To identify whether depressive symptomatology correlates with self-perception of health in patients with IPDWD. Background: Parkinson's disease is a neurodegenerative pathology characterized by motor…Non-Motor Symptoms and Comorbidities in a Cohort of Puerto Rican Parkinson’s Disease: Do They Affect Severity and Progression?
Objective: To describe for the first time the frequency of non-motor symptoms (NMS) and comorbidities in a group of idiopathic Parkinson disease (IPD) patients at…Conceptualization of the MDS Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS) prototype.
Objective: To outline the process of conceptualizing the prototype for the International Parkinson and Movement Disorder Society Parkinson's Disease Psychosis Rating Scale (MDS-PDPRS). Background: Approximately…Abstract: Trends in Movement Disorders related death in the United States from 1999 to 2020
Objective: We aimed to analyze the mortality and prevalence of movement disorders in the United States from 1999 to 2020 to compare disparities among various…Reliability and Validity of the English Version of the Parkinson Anxiety Scale
Objective: To evaluate the reliability and validity of the English version of the Parkinson Anxiety Scale (PAS) in patients with Parkinson’s disease (PD). Background: The…No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence
Objective: To explore the association between anemia and the risk of Parkinson’s disease. Background: Parkinson’s disease (PD) is a common progressive neurodegenerative neurological disorder. More than…Prodromal and overt Parkinson’s Disease Epidemiological Study in Brazil (PROBE-PD study): preliminary results
Objective: The Prodromal and overt Parkinson's Disease Epidemiological Study in Brazil (PROBE-PD) aims to estimate the prevalence of PD and other parkinsonisms (drug-induced, vascular, multiple system atrophy,…
- « Previous Page
- 1
- …
- 306
- 307
- 308
- 309
- 310
- …
- 1734
- Next Page »